检索

期
标题
作者
卷 31, 编号 31 (2024)
Natural Products in Liver Fibrosis Management: A Five-year Review
Wang T., Lu Z., Sun G., He K., Chen Z., Qu X., Han X.
PDF
(Eng)
卷 31, 编号 7 (2024)
Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases
Pi Z., Qiu X., Liu J., Shi Y., Zeng Z., Xiao R.
PDF
(Eng)
卷 31, 编号 35 (2024)
The Protective Effects of Curcumin against Renal Toxicity
Zhai J., Chen Z., Zhu Q., Guo Z., Wang N., Zhang C., Deng H., Wang S., Yang G.
PDF
(Eng)
卷 31, 编号 33 (2024)
The Metformin Immunoregulatory Actions in Tumor Suppression and Normal Tissues Protection
Gupta J., Jalil A., Abd Alzahraa Z., Aminov Z., Alsaikhan F., Ramírez-Coronel A., Ramaiah P., Najafi M.
PDF
(Eng)
卷 31, 编号 25 (2024)
Expression of Circulating miR-21 and -29 and their Association with Myocardial Fibrosis in Hypertrophic Cardiomyopathy
Tousoulis D., Tsioufis K., Vlachopoulos C., Angelopoulos A., Oikonomou E., Antonopoulos A., Theofilis P., Zisimos K., Katsarou O., Gazouli M., Lazaros G., Papanikolaou P., Siasos G.
PDF
(Eng)
卷 31, 编号 19 (2024)
Modulation of the HIF-1α-NCOA4-FTH1 Signaling Axis Regulating Ferroptosis-induced Hepatic Stellate Cell Senescence to Explore the Anti-hepatic Fibrosis Mechanism of Curcumol
Zheng Y., Wang L., Wang J., Zhao T., Wang J.
PDF
(Eng)
卷 31, 编号 18 (2024)
Recent Advances in Research on Active Compounds Against Hepatic Fibrosis
Liu C., Li S., Zhang C., Jin C.
PDF
(Eng)
卷 31, 编号 18 (2024)
miR-26a is a Key Therapeutic Target with Enormous Potential in the Diagnosis and Prognosis of Human Disease
Guan W., Chen Y., Fan Y.
PDF
(Eng)
1 - 8 的 8 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语